MX2021010213A - Agente terapeutico destinado al coronavirus que incluye extracto de elaeocarpus sylvestris como ingrediente activo. - Google Patents

Agente terapeutico destinado al coronavirus que incluye extracto de elaeocarpus sylvestris como ingrediente activo.

Info

Publication number
MX2021010213A
MX2021010213A MX2021010213A MX2021010213A MX2021010213A MX 2021010213 A MX2021010213 A MX 2021010213A MX 2021010213 A MX2021010213 A MX 2021010213A MX 2021010213 A MX2021010213 A MX 2021010213A MX 2021010213 A MX2021010213 A MX 2021010213A
Authority
MX
Mexico
Prior art keywords
active ingredient
sylvestris extract
preventing
elaeocarpus sylvestris
therapeutic agent
Prior art date
Application number
MX2021010213A
Other languages
English (en)
Inventor
Se Chan Kang
Yong Joon Jeong
Hye Lin Jeon
Yang Mi Her
Original Assignee
Genencell Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genencell Co Ltd filed Critical Genencell Co Ltd
Publication of MX2021010213A publication Critical patent/MX2021010213A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
    • A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Inorganic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)

Abstract

La presente invención se relaciona con una composición farmacéutica para prevenir, aliviar o tratar infección por coronavirus, que contiene un extracto de hoja de Elaeocarpus sylvestris como un ingrediente activo, y una composición alimenticia para prevenir o aliviar infección por coronavirus; debido a que el extracto de hoja de Elaeocarpus sylvestris exhibe excelente actividad anti viral contra el coronavirus que es un virus que causa una enfermedad respiratoria, una enfermedad digestiva, una enfermedad hepática o una enfermedad cerebral en un mamífero, particularmente, el coronavirus-19, puede utilizarse efectivamente en medicamentos y alimentos para prevenir, aliviar o tratar una enfermedad provocada por infección por coronavirus.
MX2021010213A 2020-09-07 2021-01-11 Agente terapeutico destinado al coronavirus que incluye extracto de elaeocarpus sylvestris como ingrediente activo. MX2021010213A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020200113730A KR102204299B1 (ko) 2020-09-07 2020-09-07 담팔수 추출물을 유효성분으로 포함하는 코로나 바이러스 치료제
PCT/KR2021/000347 WO2022050516A1 (ko) 2020-09-07 2021-01-11 담팔수 추출물을 유효성분으로 포함하는 코로나 바이러스 치료제

Publications (1)

Publication Number Publication Date
MX2021010213A true MX2021010213A (es) 2022-04-12

Family

ID=74304832

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2021010213A MX2021010213A (es) 2020-09-07 2021-01-11 Agente terapeutico destinado al coronavirus que incluye extracto de elaeocarpus sylvestris como ingrediente activo.

Country Status (11)

Country Link
US (1) US20220313764A1 (es)
EP (1) EP3991742A4 (es)
JP (1) JP2022551019A (es)
KR (1) KR102204299B1 (es)
CN (1) CN114502184A (es)
AR (1) AR123345A1 (es)
BR (1) BR112021017314A2 (es)
CA (1) CA3128310A1 (es)
MX (1) MX2021010213A (es)
TW (1) TWI787950B (es)
WO (1) WO2022050516A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022216107A1 (ko) * 2021-04-09 2022-10-13 주식회사 더퓨쳐 담팔수 추출물 또는 이의 정제물을 유효성분으로 함유하는 항암용 조성물
KR102538022B1 (ko) * 2021-04-12 2023-06-07 주식회사 더퓨쳐 담팔수 추출물 또는 이의 정제물을 유효성분으로 함유하는 항균용 조성물
KR20230028163A (ko) 2021-08-21 2023-02-28 주식회사 엑소코바이오 항바이러스 활성이 강화된 엑소좀의 생산방법 및 이의 응용
KR102408542B1 (ko) * 2021-11-29 2022-06-16 농업회사법인 휴림황칠(주) 반려동물용 항균 및 항코로나 바이러스 조성물, 및 그 제조방법
KR20230143964A (ko) 2022-04-06 2023-10-13 서울대학교산학협력단 바이러스 감염증의 예방 또는 치료용 약학 조성물
CN114796172A (zh) * 2022-05-26 2022-07-29 中国科学院昆明植物研究所 具有乙酰胆碱酯酶抑制活性的山杜英枝叶提取物活性部位和应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100791108B1 (ko) * 2006-11-06 2008-01-03 제주대학교 산학협력단 방사선 방호효과를 갖는 담팔수 분획농축물과 그 제조방법
KR20100080972A (ko) * 2009-01-05 2010-07-14 김선일 나무수액 발효물과 그 이용방법.
CN103561754A (zh) * 2011-03-28 2014-02-05 玫琳凯有限公司 包含植物提取物的局部护肤制剂
KR101834872B1 (ko) 2016-09-09 2018-04-13 주식회사 제넨셀 담팔수 추출물 또는 이의 분획물을 유효 성분으로 포함하는 알파 계열 허피스 바이러스 감염증의 예방 또는 치료용 약제학적 조성물
KR101874745B1 (ko) * 2017-04-19 2018-07-04 가천대학교 산학협력단 담팔수 추출물, 이의 분획물 또는 이로부터 분리된 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물
KR20190121956A (ko) * 2018-04-19 2019-10-29 가천대학교 산학협력단 담팔수 추출물에서 분리한 화합물을 유효성분으로 함유하는 수두-대상포진 바이러스 억제용 약학적 조성물

Also Published As

Publication number Publication date
AR123345A1 (es) 2022-11-23
JP2022551019A (ja) 2022-12-07
BR112021017314A2 (pt) 2023-03-14
CN114502184A (zh) 2022-05-13
EP3991742A4 (en) 2023-02-01
TW202210088A (zh) 2022-03-16
WO2022050516A1 (ko) 2022-03-10
TWI787950B (zh) 2022-12-21
EP3991742A1 (en) 2022-05-04
CA3128310A1 (en) 2022-03-07
US20220313764A1 (en) 2022-10-06
KR102204299B1 (ko) 2021-01-20

Similar Documents

Publication Publication Date Title
MX2021010213A (es) Agente terapeutico destinado al coronavirus que incluye extracto de elaeocarpus sylvestris como ingrediente activo.
WO2021207409A3 (en) Small molecule inhibitors of sars-cov-2 viral replication and uses thereof
SA521421897B1 (ar) تركيبة تعتمد على جزء من نباتات طبية أو مستخلصاتها واستخداماتها ومنتجاتها
MX2019012884A (es) Terapia de combinacion.
ZA202211060B (en) Anti-viral compounds and methods for administration thereof
MX2012007410A (es) Compuestos antivirales novedosos.
WO2006050489A3 (en) Methods of entrapping, inactivating, and removing viral infections by the administration of respiratory tract compositions
MD4430B1 (ro) Compoziţii şi metode de tratament al hepatitei virale C
WO2020076760A3 (en) Sphingoid compounds for use in the prophylaxis and/or therapy of a viral infection
UA92498C2 (ru) Каннабиноидно активный фармацевтический ингредиент для улучшенных дозированных форм
JP2017514911A5 (es)
ZA202211004B (en) 3clpro-targeting phillyrin, derivative thereof, and use thereof against novel coronavirus
MX2021009219A (es) Triamtereno o nolatrexed para su uso en el tratamiento de la fenilcetonuria.
WO2022192594A3 (en) Nucleic acid molecules and vaccines comprising same for the prevention and treatment of coronavirus infections and disease
WO2016159582A3 (ko) 형개 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
WO2021222584A3 (en) Inhibition of sars-cov-2 viral entry through administration of lactoferrin and uses thereof
MX2022013722A (es) Cisteamina para el tratamiento de infección por sars-cov-2.
PT1796702E (pt) Utilização de óleo de lavanda para profilaxia e tratamento de distúrbios de somatização e da doença de stress pós-traumático
WO2022065970A3 (ko) 천연물 혼합 추출물을 포함하는 코로나바이러스 감염 예방 또는 치료용 조성물
NZ599039A (en) Picrorhiza kurroa extract for prevention, elimination and treatment of rna viruses and infection or diseases caused by the same in humans, animals and in biotech industry
WO2006089120A3 (en) Compositions, methods of use and preparation of 2,6-diisopropyl phenol and analogs for ischemic injury
MX2022005909A (es) Composicion para la prevencion, alivio, o tratamiento de enfermedades respiratorias.
WO2016159584A3 (ko) 상지 또는 상백피 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
WO2016159583A3 (ko) 지구자 추출물을 유효성분으로 함유하는 선천면역 증진 및 항바이러스용 조성물
MX2023000154A (es) Inhibidores de la esfingomielinasa acida para prevenir y tratar la enfermedad covid-19.